Skip to main content
Top
Published in: BMC Nephrology 1/2016

Open Access 01-12-2016 | Study protocol

Evaluation of the quality of care of a haemodialysis public-private partnership programme for patients with end-stage renal disease

Authors: Julie Y. Chen, Eric Y. F. Wan, Karina H. Y. Chan, Anca K. C. Chan, Frank W. K. Chan, Cindy L. K. Lam

Published in: BMC Nephrology | Issue 1/2016

Login to get access

Abstract

Background

Haemodialysis (HD) is one of the life-saving options for patients with end stage renal disease but demand for this treatment exceeds capacity in publicly funded hospitals. One novel approach to addressing this problem is through a shared-care model whereby government hospitals partner with qualified private HD service providers to increase the accessibility of HD for needy patients. The aim of this study is to evaluate and enhance the quality of care (QOC) provided in such a shared-care programme in Hong Kong, the Haemodialysis Public-Private Partnership Programme (HD-PPP).

Methods/Design

This is a longitudinal study based on Action Learning and Audit Spiral methodologies to measure the achievement of pre-set target standards for the HD-PPP programme over three evaluation cycles. The QOC evaluation framework is comprised of structure, process and outcome criteria with target standards in each domain developed from review of the evidence and in close collaboration with the HD-PPP working group. During each evaluation cycle, coordinators of each study site complete a questionnaire to determine adherence with structural criteria of care. Process and clinical outcomes, such as adverse events and dialysis adequacy, are extracted from the patient records of consenting study participants while face-to-face interviews are conducted to ascertain patient-reported outcomes such as self-efficacy and health-related quality of life.

Discussion

The study relies on the successful implementation of partnership-based action research to develop an evidence-based and pragmatic framework for evaluation of quality of care in an iterative fashion, and to use it to identify possible areas of quality enhancements in a shared-care programme for HD patients. The approach we take in this study emphasizes partnership and engagement with the clinical and administrative programme team, a robust but flexible evaluation framework, direct observation and the potential to realize positive change. The experience will be useful to inform the process of coordinating research studies involving multiple stakeholders and results will help to guide service planning and policy decision making.

Trial registration

US Clinical Trial Registry NCT02307903
Appendix
Available only for authorised users
Literature
1.
go back to reference Gibney N, Hoste E, Burdmann EA, Bunchman T, Kher V, Viswanathan R, Mehta RL, Ronco C. Timing of initiation and discontinuation of renal replacement therapy in AKI: unanswered Key questions. Clin J Am Soc Nephrol. 2008;3(3):876–80.CrossRefPubMed Gibney N, Hoste E, Burdmann EA, Bunchman T, Kher V, Viswanathan R, Mehta RL, Ronco C. Timing of initiation and discontinuation of renal replacement therapy in AKI: unanswered Key questions. Clin J Am Soc Nephrol. 2008;3(3):876–80.CrossRefPubMed
2.
go back to reference Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–128.CrossRefPubMed Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–128.CrossRefPubMed
3.
go back to reference Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, Zhao M-h, Lv J, Garg AX, Knight J, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975–82.CrossRefPubMed Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, Zhao M-h, Lv J, Garg AX, Knight J, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975–82.CrossRefPubMed
4.
go back to reference United States Renal Data System. 2009 annual data report: atlas of chronic kidney disease and End-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2009. United States Renal Data System. 2009 annual data report: atlas of chronic kidney disease and End-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2009.
5.
go back to reference Yu AW-Y, Chau K-F, Ho Y-W, Li PK-T. Development of the “peritoneal dialysis first” model in Hong Kong. Perit Dial Int. 2007;27(Supplement 2):S53–5.PubMed Yu AW-Y, Chau K-F, Ho Y-W, Li PK-T. Development of the “peritoneal dialysis first” model in Hong Kong. Perit Dial Int. 2007;27(Supplement 2):S53–5.PubMed
6.
go back to reference Roderick P, Armitage A, Nicholson T, Mehta R, Gerard K, Mullee M, Drey N, Lamping D, Feest T, Greenwood R, et al. A clinical and cost evaluation of hemodialysis in renal satellite units in England and Wales. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2004;44(1):121–31.CrossRef Roderick P, Armitage A, Nicholson T, Mehta R, Gerard K, Mullee M, Drey N, Lamping D, Feest T, Greenwood R, et al. A clinical and cost evaluation of hemodialysis in renal satellite units in England and Wales. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2004;44(1):121–31.CrossRef
7.
go back to reference Mowatt G, Vale L, MacLeod A. Systematic review of the effectiveness of home versus hospital or satellite unit hemodialysis for people with end-stage renal failure. Int J Technol Assess Health Care. 2004;20(03):258–68.CrossRefPubMed Mowatt G, Vale L, MacLeod A. Systematic review of the effectiveness of home versus hospital or satellite unit hemodialysis for people with end-stage renal failure. Int J Technol Assess Health Care. 2004;20(03):258–68.CrossRefPubMed
9.
go back to reference Revans RW. Action learning: New techniques for management. London: Blond and Briggs Ltd.; 1980. Revans RW. Action learning: New techniques for management. London: Blond and Briggs Ltd.; 1980.
12.
go back to reference Tao X, Chow SK, Wong FK. Determining the validity and reliability of the Chinese version of the Kidney Disease Quality of Life Questionnaire (KDQOL-36). BMC Nephrol. 2014;15:115.CrossRefPubMedPubMedCentral Tao X, Chow SK, Wong FK. Determining the validity and reliability of the Chinese version of the Kidney Disease Quality of Life Questionnaire (KDQOL-36). BMC Nephrol. 2014;15:115.CrossRefPubMedPubMedCentral
13.
go back to reference Lam ET, Lam CL, Fong DY, Huang WW. Is the SF-12 version 2 Health Survey a valid and equivalent substitute for the SF-36 version 2 Health Survey for the Chinese? J Eval Clin Pract. 2013;19(1):200–8.CrossRefPubMed Lam ET, Lam CL, Fong DY, Huang WW. Is the SF-12 version 2 Health Survey a valid and equivalent substitute for the SF-36 version 2 Health Survey for the Chinese? J Eval Clin Pract. 2013;19(1):200–8.CrossRefPubMed
14.
go back to reference Howie J, Heaney DJ, Maxwell M, Walker JJ. A comparison of a Patient Enablement Instrument (PEI) against two established satisfaction scales as an outcome measure of primary care consultations. Fam Pract. 1998;15(2):165–71.CrossRefPubMed Howie J, Heaney DJ, Maxwell M, Walker JJ. A comparison of a Patient Enablement Instrument (PEI) against two established satisfaction scales as an outcome measure of primary care consultations. Fam Pract. 1998;15(2):165–71.CrossRefPubMed
15.
go back to reference Lam CL, Yuen NY, Mercer SW, Wong W. A pilot study on the validity and reliability of the Patient Enablement Instrument (PEI) in a Chinese population. Fam Pract. 2010;27(4):395–403.CrossRefPubMed Lam CL, Yuen NY, Mercer SW, Wong W. A pilot study on the validity and reliability of the Patient Enablement Instrument (PEI) in a Chinese population. Fam Pract. 2010;27(4):395–403.CrossRefPubMed
16.
go back to reference Jaeschke R, Singer J, Guyatt GH. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10(4):407–15.CrossRefPubMed Jaeschke R, Singer J, Guyatt GH. Measurement of health status: ascertaining the minimal clinically important difference. Control Clin Trials. 1989;10(4):407–15.CrossRefPubMed
17.
go back to reference Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16(1):139–44.PubMed Osoba D, Rodrigues G, Myles J, Zee B, Pater J. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16(1):139–44.PubMed
18.
go back to reference Ho Y-W, Chau K-F, Choy B-Y, Fung K-S, Cheng Y-L, Kwan T-H, Wong P-N, Lai W-M, Yuen S-K, Lo SH-K, et al. Hong Kong renal registry report 2012. Hong Kong Journal of Nephrology. 2013;15:28–43.CrossRef Ho Y-W, Chau K-F, Choy B-Y, Fung K-S, Cheng Y-L, Kwan T-H, Wong P-N, Lai W-M, Yuen S-K, Lo SH-K, et al. Hong Kong renal registry report 2012. Hong Kong Journal of Nephrology. 2013;15:28–43.CrossRef
19.
go back to reference Fung CS, Weng CY, Dai DS, Kwok RL, Tsui EL, Wan YF, Wong W, Wong CK, Fong DY, Lam CL. Evaluation of the quality of care of a multi-disciplinary risk factor assessment and management programme (RAMP) for diabetic patients. BMC Fam Pract. 2012;13:116–25.CrossRefPubMedPubMedCentral Fung CS, Weng CY, Dai DS, Kwok RL, Tsui EL, Wan YF, Wong W, Wong CK, Fong DY, Lam CL. Evaluation of the quality of care of a multi-disciplinary risk factor assessment and management programme (RAMP) for diabetic patients. BMC Fam Pract. 2012;13:116–25.CrossRefPubMedPubMedCentral
20.
go back to reference Yu EY, Wan EY, Chan KH, Wong CK, Kwok RL, Fong DY, Lam CL. Evaluation of the quality of care of a multi-disciplinary Risk Factor Assessment and Management Programme for Hypertension (RAMP-HT). BMC Fam Pract. 2015;16(1):71.CrossRefPubMedPubMedCentral Yu EY, Wan EY, Chan KH, Wong CK, Kwok RL, Fong DY, Lam CL. Evaluation of the quality of care of a multi-disciplinary Risk Factor Assessment and Management Programme for Hypertension (RAMP-HT). BMC Fam Pract. 2015;16(1):71.CrossRefPubMedPubMedCentral
Metadata
Title
Evaluation of the quality of care of a haemodialysis public-private partnership programme for patients with end-stage renal disease
Authors
Julie Y. Chen
Eric Y. F. Wan
Karina H. Y. Chan
Anca K. C. Chan
Frank W. K. Chan
Cindy L. K. Lam
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2016
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-016-0284-9

Other articles of this Issue 1/2016

BMC Nephrology 1/2016 Go to the issue